Life Sciences Archives - Page 10 of 22 - Becker's Hospital Review

A new weight loss pill by 2026 | J&J buys drugmaker for $14.6B | Antidepressant fails in final stage | Top-paying healthcare jobs in 2025

January 15, 2025 BHR Newsletter 1. J&J set to acquire drugmaker for $14.6B Full story 2. New weight loss pill to be approved by early 2026: Eli Lilly Full story 3. The top-paying healthcare jobs for 2025 Full story 4.…

Google's ALS drug fails trial | Eli Lilly joins GLP-1 shortage lawsuit | Trump's impact on drug prices | 5 recent drug recalls

January 8, 2025 BHR Newsletter 1. Google's ALS drug fails phase 3 trial Full story 2. Eli Lilly to join lawsuit over GLP-1 shortage: 4 things to know Full story 3. Bone cancer drug linked to cardiovascular risk, study suggests…

Drug company to cut 65% of staff | Flu, COVID vaccines get fast-track status | Study links Ozempic to vision loss | FDA recalls 230K bottles of antidepressant

December 18, 2024 BHR Newsletter 1. FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates Full story 2. Eli Lilly, telehealth firm team up to expand Zepbound access Full story 3. Massachusetts drug company to cut 65%…

Zepbound beats out Wegovy in study | The race to create an oral GLP-1 drug | Walgreens eyes private equity sale | 20 drugs now in shortage

December 11, 2024 BHR Newsletter 1. Zepbound outperforms Wegovy for weight loss: Study Full story 2. The race to create an oral GLP-1 obesity drug: 4 things to know Full story 3. Walgreens eyes private equity sale: WSJ report Full…

Ozempic is getting cheaper | Sanofi adds $600M plant | 6 GLP-1 study findings to know | Forbes honors '30 Under 30' in healthcare

December 4, 2024 BHR Newsletter 1. Sanofi adds new $600M manufacturing plant Full story 2. Ozempic is becoming cheaper Full story 3. Forbes honors '30 Under 30' in healthcare for 2025 Full story 4. 400 health systems gather to boost…

Controversial drug trial halted | RFK on Ozempic | 1st gene therapy delivered into brain approved | Biden proposes Medicare coverage for weight loss drugs

November 27, 2024 BHR Newsletter 1. RFK Jr.'s comments on Ozempic: What to know Full story 2. Controversial Alzheimer's drug trial halted Full story 3. Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know Full story…

Mounjaro lowers diabetes risk | FDA rejects liver disease drug | 53% of adults are eligible for Ozempic | Trump taps Dr. Oz for CMS lead

November 20, 2024 BHR Newsletter 1. FDA rejects full approval of liver disease drug Full story 2. Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study Full story 3. President-elect Trump taps Dr. Oz for CMS administrator: 10…

COVID-Flu vaccine trial advances | Warning added to Ozempic, Mounjaro labels | FDA could pull decongestant | UnitedHealth sued over Amedisys deal

November 13, 2024 BHR Newsletter 1. FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels Full story 2. FDA lifts clinical hold on combined COVID-19-influenza vaccine trials Full story 3. J&J sues government over 340B rebate plan Full story…

Trump wins election: 7 notes | Ozempic, Wegovy shortages fixes | Patient dies in gene-therapy trial | US drugmakers to cut reliance on China

November 6, 2024 BHR Newsletter 1. 2 drug companies to pay $49M in alleged inflation scheme Full story 2. Ozempic, Wegovy shortages resolved: FDA Full story 3. Trump wins election: 7 notes for healthcare leaders Full story 4. Up to…

Trump, Harris on drug prices | FDA recalls antidepressant bottles | Alzheimer's drug trials raise ethical concerns | 9 drugs in shortage

October 30, 2024 BHR Newsletter 1. FDA recalls 7,000 antidepressant bottles Full story 2. Alzheimer's drug trials raise ethical concerns over risk disclosure Full story 3. Where Trump, Harris stand on prescription drug prices: 6 notes Full story 4. Transform…